Korean J Fam Med.  2017 Jan;38(1):40-42. 10.4082/kjfm.2017.38.1.40.

Escitalopram-Induced Amenorrhea and False Positive Urine Pregnancy Test

Affiliations
  • 1Department of Psychiatry, Creighton University School of Medicine, Omaha, USA. vidyaselvaraj@creighton.edu
  • 2Department of Obstetrics and Gynecology, Creighton University School of Medicine, Omaha, USA.
  • 3Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, USA.

Abstract

Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.

Keyword

Selective Serotonin Reuptake Inhibitors; Hyperprolactinemia; Amenorrhea; Immunologic Pregnancy Tests; Case Reports

MeSH Terms

Adult
Amenorrhea*
Anxiety Disorders
Citalopram
Depressive Disorder, Major
Female
Humans
Hyperprolactinemia
Pregnancy
Pregnancy Tests*
Pregnancy Tests, Immunologic
Pregnancy*
Serotonin
Serotonin Uptake Inhibitors
United States Food and Drug Administration
Citalopram
Serotonin
Serotonin Uptake Inhibitors
Full Text Links
  • KJFM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr